Compare GH & SUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GH | SUZ |
|---|---|---|
| Founded | 2011 | 1924 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3B | 11.8B |
| IPO Year | 2018 | 2002 |
| Metric | GH | SUZ |
|---|---|---|
| Price | $94.00 | $11.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 20 | 0 |
| Target Price | ★ $117.80 | N/A |
| AVG Volume (30 Days) | 1.9M | ★ 3.3M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.68% |
| EPS Growth | ★ 6.74 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $982,021,000.00 | N/A |
| Revenue This Year | $29.73 | $13.83 |
| Revenue Next Year | $27.71 | $13.42 |
| P/E Ratio | ★ N/A | $5.58 |
| Revenue Growth | ★ 32.88 | N/A |
| 52 Week Low | $34.91 | $8.41 |
| 52 Week High | $120.74 | $11.54 |
| Indicator | GH | SUZ |
|---|---|---|
| Relative Strength Index (RSI) | 36.72 | 70.70 |
| Support Level | $54.39 | $9.28 |
| Resistance Level | $115.77 | N/A |
| Average True Range (ATR) | 6.12 | 0.24 |
| MACD | -1.26 | 0.06 |
| Stochastic Oscillator | 9.73 | 86.63 |
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.